The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis DOI Creative Commons
Alejandro Borrego-Ruiz, Juan J. Borrego

Life, Год журнала: 2025, Номер 15(6), С. 834 - 834

Опубликована: Май 22, 2025

Specific gut microorganisms and their metabolic by-products have been identified as key regulators of host physiology, contributing to the modulation immune system, inflammatory processes, brain function, behavior, which highlights microbiome a potential modulator neurobiological mechanisms involved in substance use disorders. This narrative review provides an updated overview how drugs abuse influence composition dynamics human bacterial dysbiosis may be factor disorders by modulating communication between brain. Thus, examining commonly abused substances such alcohol, psychostimulants, opioids, cannabinoids, nicotine, this aimed deepen understanding bidirectional relationship use. There is evidence indicating that alterations addiction through changes gut-brain signaling. Furthermore, its metabolites not only result from disorders, but could also modulate behavioral responses abuse. Although exact modulates are fully understood, microbial products short-chain fatty acids, tryptophan metabolites, bile neurotransmitters suggested play role process influencing blood–brain barrier permeability, activation, neural signaling, gene expression. Therefore, manipulating or represent promising approach for enhancing disorder treatments, identifying individuals at increased risk pathological drug use, elucidating substance-related behaviors.

Язык: Английский

Staphylococcus aureus Infections and Human Intestinal Microbiota DOI Creative Commons

Aotong Liu,

Shari Garrett,

Wanqing Hong

и другие.

Pathogens, Год журнала: 2024, Номер 13(4), С. 276 - 276

Опубликована: Март 24, 2024

Staphylococcus aureus (S. aureus) is a common pathogen that can cause many human diseases, such as skin infection, food poisoning, endocarditis, and sepsis. These diseases be minor infections or life-threatening, requiring complex medical management resulting in substantial healthcare costs. Meanwhile, the critically ignored “organ,” intestinal microbiome greatly impacts physiological health, not only gastrointestinal but also disorders beyond gut. However, correlation between S. infection microbial homeostasis largely unknown. Here, we summarized recent progress understanding their interactions with intestine. summarizations will help us understand mechanisms behind these crosstalk challenges are facing now, which could contribute to preventing infections, effective treatment investigation, vaccine development.

Язык: Английский

Процитировано

23

Dietary polyphenols regulate appetite mechanism via gut-brain axis and gut homeostasis DOI

Hongyan Liu,

Xue Guo, Kexin Jiang

и другие.

Food Chemistry, Год журнала: 2024, Номер 446, С. 138739 - 138739

Опубликована: Фев. 16, 2024

Язык: Английский

Процитировано

20

The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis DOI Open Access
Laura Bărcuțean, Smaranda Maier, Mihai Burai Patrascu

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(6), С. 3198 - 3198

Опубликована: Март 11, 2024

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative central nervous system (CNS) disorder, characterized by focal inflammation, demyelination, irreversible axonal loss neurodegeneration. The proposed mechanism involves auto-reactive T lymphocytes crossing the blood–brain barrier (BBB), contributing to inflammation demyelination. Pro-inflammatory Th1 Th17 are pivotal in MS pathogenesis, highlighting an imbalanced interaction with regulatory cells. Dysbiosis gut microbiota, microbial imbalance implicated systemic yet its exact role remains elusive. Short-chain fatty acids (SCFAs), including valerate, butyrate, propionate, acetate, produced through dietary fiber fermentation modulate immune responses. Particularly, butyrate propionate exhibit pronounced anti-inflammatory effects both CNS. These SCFAs influence lymphocyte expression BBB permeability. This review discusses potential therapeutic implications of SCFA MS, their ability gut–brain axis restore balance.

Язык: Английский

Процитировано

14

Short-chain fatty acids and cancer DOI
Shan Li,

Yixin Duan,

Shudi Luo

и другие.

Trends in cancer, Год журнала: 2024, Номер unknown

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

11

Dietary Guidance, Sensory, Health and Safety Considerations When Choosing Low and No-Calorie Sweeteners DOI Open Access
John L. Sievenpiper,

Sidd Purkayastha,

V. Lee Grotz

и другие.

Nutrients, Год журнала: 2025, Номер 17(5), С. 793 - 793

Опубликована: Фев. 25, 2025

The growing global focus on the adverse health conditions associated with excessive sugar consumption has prompted and policy organizations as well public to take a more mindful approach wellness. In response, food beverage companies have proactively innovated reformulated their product portfolios incorporate low no-calorie sweeteners (LNCSs) viable alternatives sugar. LNCSs offer an effective safe delivering sweetness foods beverages reducing calories intake while contributing enjoyment of eating. objective this paper is enhance understanding segmentation definitions, dietary reduction guidance, front-of-package labeling, taste sensory perception physiology, metabolic efficacy impact, overall safety

Язык: Английский

Процитировано

2

Could a Mediterranean Diet Modulate Alzheimer’s Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration DOI Creative Commons
Alice Njolke Mafe, Dietrich Büsselberg

Foods, Год журнала: 2025, Номер 14(9), С. 1559 - 1559

Опубликована: Апрель 29, 2025

Neurodegenerative disorders such as Alzheimer's disease (AD), the most common form of dementia, represent a growing global health crisis, yet current treatment strategies remain primarily palliative. Recent studies have shown that neurodegeneration through complex interactions within gut-brain axis largely depends on gut microbiota and its metabolites. This review explores intricate molecular mechanisms linking dysbiosis to cognitive decline, emphasizing impact microbial metabolites, including short-chain fatty acids (SCFAs), bile acids, tryptophan neuroinflammation, blood-brain barrier (BBB) integrity, amyloid-β tau pathology. The paper highlights major microbiome signatures associated with disease, detailing their metabolic pathways inflammatory crosstalk. Dietary interventions promise in modulating composition, potentially mitigating neurodegenerative processes. critically examines influence dietary patterns, Mediterranean Western diets, microbiota-mediated neuroprotection. Bioactive compounds like prebiotics, omega-3 polyphenols exhibit neuroprotective effects by reducing neuroinflammation. Furthermore, it discusses emerging microbiome-based therapeutic strategies, probiotics, postbiotics, fecal transplantation (FMT), potential for slowing progression. Despite these advances, several knowledge gaps remain, interindividual variability responses need large-scale, longitudinal studies. study proposes an integrative, precision medicine approach, incorporating science into paradigms. Ultimately, cognizance at mechanistic level could unlock novel avenues, offering non-invasive, diet-based strategy managing improving health.

Язык: Английский

Процитировано

2

The Role of Probiotics in Modulating Gut Microbiota and Metabolic Health for Weight Management: A Mini Review DOI Open Access
Qutaibah Oudat, Anas Okour

Deleted Journal, Год журнала: 2025, Номер 70(1), С. 5 - 5

Опубликована: Фев. 5, 2025

The rising global prevalence of obesity and its associated metabolic disorders highlights the urgent need for innovative, sustainable interventions. Probiotics, as modulators gut microbiota, have emerged promising agents in weight management by influencing health. This mini-review explores role probiotics modulating microbiota to support energy metabolism, appetite regulation, fat storage. Evidence underscores strain-specific benefits probiotics, such Lactobacillus gasseri SBT2055, Bifidobacterium breve B-3, Akkermansia muciniphila, reducing visceral fat, improving glucose mitigating obesity-related inflammation. mechanisms underlying these effects include short-chain fatty acid (SCFA) production, modulation appetite-regulating hormones, improvements barrier integrity. While findings are promising, variability outcomes importance tailored probiotic interventions standardized methodologies future research. By addressing challenges, can serve integral components personalized nutrition strategies, advancing both health public objectives.

Язык: Английский

Процитировано

1

Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection DOI Creative Commons
Chou‐Yi Hsu, Lusine Khachatryan, Nada Khairi Younis

и другие.

Frontiers in Microbiology, Год журнала: 2024, Номер 15

Опубликована: Окт. 8, 2024

The infant gut microbiota undergoes significant changes during early life, which are essential for immune system maturation, nutrient absorption, and metabolic programming. Among the various microbial metabolites, short-chain fatty acids (SCFAs), primarily acetate, propionate, butyrate, produced through fermentation of dietary fibers by bacteria, have emerged as critical modulators host-microbiota interactions. SCFAs serve energy sources colonic cells play pivotal roles in regulating responses, maintaining barrier integrity, influencing systemic pathways. Recent research highlights potential neuroprotective effects pediatric populations. Disruptions composition SCFA production increasingly associated with a range health issues, including obesity, allergic disorders, inflammatory bowel disease (IBD), neurodevelopmental disorders. This review synthesizes current knowledge on role microbiota-derived health, emphasizing their contributions from development to neuroprotection. It also underscores need further unravel precise mechanisms influence develop targeted interventions that leverage therapeutic benefits.

Язык: Английский

Процитировано

9

Appraising the role of biotics and fermented foods in gut microbiota modulation and sleep regulation DOI Open Access
Akanksha Singh, Pradeep Singh Negi

Journal of Food Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 3, 2025

Abstract Sleep disturbances are increasingly prevalent, significantly impacting physical and mental health. Recent research reveals a bidirectional relationship between gut microbiota sleep, mediated through the microbiota–gut–brain axis. This review examines role of in sleep physiology explores how biotics, including probiotics, prebiotics, synbiotics, postbiotics, fermented foods, can enhance quality. Drawing from animal human studies, we discuss neurobiological mechanisms by which biotics may influence modulation neurotransmitters, immune responses, hormonal regulation. Key microbial metabolites, such as short‐chain fatty acids, highlighted for their supporting sleep‐related neurochemical processes. Additionally, this presents dietary strategies food processing technologies, like fermentation, innovative approaches enhancement. Although promising, available has limitations, small sample sizes, variability biotic strains dosages, reliance on subjective assessments. underscores need standardized protocols, objective assessments polysomnography, personalized interventions. Emerging findings highlight therapeutic potential improvement, though further large‐scale trials essential to refine strain selection, dosage, formulation. interdisciplinary exploration seeks advance food‐based interventions holistic managing disorders improving quality life.

Язык: Английский

Процитировано

1

Blue mussel (Mytilus edulis L.) exposure to nylon microfibers leads to a shift in digestive gland microbiota DOI Creative Commons

Giulia Stilo,

Chiara Beltramo, Eleni Christoforou

и другие.

Environmental Pollution, Год журнала: 2025, Номер unknown, С. 125914 - 125914

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

1